Referencias:
1. Sociedad Argentina de Cardiología. Uso apropiado de las estatinas en la Argentina. Documento de posición. Sac. 2018 [consultado en agosto de 2022]. Disponible en la web: https://www.sac.org.ar/wp-content/uploads/2018/06/documento-de-posicion-consenso-de-estatinas-2018.pdf 2. Hodkinson A, Tsimpida D, Kontopantelis E, Rutter MK and Panagioti M. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ. 2022; 376:e067731. Doi:10.1136/bmj-2021-067731. 3. Iyen B, Akyea RK, Weng S, Kai J and Qureshi N. Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care. Open Heart. 2021; 8(2):e001817. Doi:10.1136/openhrt-2021-001817. 4. Pradhan A, Tiwari A, Caminiti G, Salimei C, Muscoli S, Sethi R, et al. Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A review and current status. Int J Environ Res Public Health. 2022; 19(15):8977. Doi:10.3390/ijerph19158977.